701 Pennsylvania Ave. N.W.
Suite 700
Washington, DC 20004
(202) 737-5980
dmaa@dmaa.org
www.dmaa.org

Sunday, Sept. 7, 1:30 - 2 p.m.
PACESETTERS SERIES

For almost two decades, clinicians have attempted to monitor patients with chronic conditions, such as congestive heart failure, in their home environment. Many landmark studies have attempted to quantify the benefit of critical outcomes, such as mortality, hospitalization and cost effectiveness. Although each trial was scientifically based, results of their primary outcomes varied widely from study to study. Hear about a meta-analysis of key trials in remote patient management with interim results from trials currently in progress. Variability in results from these trials can be attributed to differences in home monitoring technologies, variation in disease management programs and lack of adequate power in study sample sizes, duration and other metrics. Understand value models and return on investment calculations.

Mark A. Johnson, BSEE, MBA, is clinical trials manager for Intel Corporation's Digital Health division. He is a 20-year veteran of the medical device industry in engineering, business development, clinical studies and marketing. Previously, he was a business development manager for the first implantable RPM technology introduced by Biotronik.

One medical center is using a diabetes management solution that runs on mobile phones to reduce the HbA1c levels of diabetes patients. The program began a rolling 12-month pilot in 2007 targeted at 59 diabetes patients with blood glucose levels greater than 9 percent. Patients starting with HbA1c between eight and nine reduced HbA1c by 0.91 points, while patients with HbA1c more than nine reduced HbA1c by 2.22 points. Learn how patients with diabetes can benefit from an integrated approach of case management and wireless technology to decrease their risk factors and better manage their condition. Discover the role of software applications that run on mobile phones to increase the effectiveness and efficiency of disease management.

Peter Boland, PhD, is director of business development for BeWell Mobile Technology. As a management consultant on strategy, product development and technology innovation, he works with many leading stakeholders in health care. He has a doctorate from UCLA and a post-graduate certificate from Harvard's Executive Program in health policy and management.

Neil Thamawatanakul, MBA, is a consultant to Medical Group Administration with Riverside Medical Center, Kaiser Permanente. He co-leads the Mobile Wellness Program for managing high-risk patients with diabetes through two-way interactive cell phone communications. He was honored as a team recipient of the 2006 Vohs Award for operational excellence at Riverside Medical Center.

Self-management interventions should improve quality of life and health by teaching patients the skills needed to effectively take personal control in the face of chronic illness. Hear about outcomes data on 5,141 health plan members with one or more chronic illnesses who participated in a tailored, online chronic illness self-management program. Self-reported improvements were found in perceived health, quality of life, self-confidence, self-management skills, provider relationships and medication adherence, with decreased stress, worry and productivity impairment. Understand the three key components of an effective self-management program, as well as the 90-day outcomes on the nine critical components of effective chronic illness self-management.

Jane Livingston, RD, LDN, CDE, with preventive health services for Highmark Blue Cross Blue Shield, leads program development and implementation of The Highmark Preventive Health Alliance and worksite health promotion. She is a registered dietitian, a Pennsylvania licensed dietitian-nutritionist and a certified diabetes educator.

Kevin J. Wildenhaus, PhD, is the director of behavioral science and data analytics at HealthMedia Inc. An expert in health behavior change, he has given many national presentations and workshops. Previously, he was director of behavioral science in the department of family medicine for Henry Ford Health System.

Interactive, Web-based personal health records (PHRs) are widely recognized as one of the most important new health care tools available, showing tremendous promise and potential for improving care by better connecting physicians and patients in the health care dialogue. Learn how a collaborative new study from the American Heart Association, American Stroke Association and an independent practice association of more than 1,500 physicians examined the benefits of PHR services for medication adherence, patient satisfaction and office efficiency—specifically with patients who are prescribed antihypertensive and statin medications. Understand the real-world patient use and acceptance for PHRs, as well as the study's metrics, including patient participation, physician practice efficiency, patient adherence, patient satisfaction, physician practice satisfaction and payer economics.

Edward Fotsch, MD, is chief executive of Medem, the corporation founded in 1999 by the American Medical Association and six leading medical societies to deliver the country's premier, secure, online physician-patient communications network. Dr. Fotsch's professional experience spans health care, information technology and business start-up/syndication commerce, including more than 10 years of clinical practice.

Fiona Wilson, MD, is the chief quality officer for Brown & Toland Medical Group, a San Francisco-based independent practice association of more than 1,500 physicians serving 270,000 patients. A graduate of Harvard Medical School, Dr. Wilson completed her residency at the University of California, San Francisco, where she also served as medical director of internal medicine.

The use of health risk assessments (HRAs) continues to grow as a tool to identify patients who are candidates for wellness and disease management programs. Learn about a study, conducted in an employer population, that required completion of a self-reported HRA and biometric screening to receive discounts on health insurance. The biometric scores were more likely to identify patients at higher risk (18 percent vs. 1 percent for self-report) and correlated to greater absenteeism (p<.05), with those in the highest-risk group being 122 percent more likely to miss work. Discover the relationship between biometric risk scores and employee productivity, and new solutions to compensate for limitations of self-reported HRAs, including biometrics and predictive modeling, in identifying patients at highest risk for adverse health and reduced productivity.

Mark Frisse, MD, MBA, MSC, is the Accenture Professor of Biomedical Informatics for Vanderbilt University. Previously, he served as vice president at First Consulting Group and chief medical officer at the Washington University School of Medicine.

Pari Mistry, MD, MHSA, is a health care consumerism advocate for Plastipak Packaging Inc., a multistate manufacturing company based in Michigan. She holds a master's degree in health care administration from the University of Michigan and a doctorate from the American University of the Caribbean. Her unique combination of experience in clinical medicine and management helps her to affect medical costs while improving quality of care to Plastipak Packaging's 4,700 associates.

Adam Hobgood, MS, is director of the Center for Health Research for Healthways Inc., where he focuses on outcomes research and predictive modeling. Previously, he served as a statistician in the pharmaceutical industry for Covance. He holds a master's degree in statistics from the University of Kentucky and a bachelor's in mathematics from Freed-Hardeman University.

The disease management community can play a leading role in the march toward data interoperability, with its long experience coordinating information from many players on behalf of the patient. But the opposite also could be true, as interoperability threatens to disrupt existing disease management business models. Explore drivers and barriers toward data interoperability and specific actions members of the disease management community can take to assume leadership roles in advancing the national health information technology agenda. Understand the role of large, non-health care companies, such as Google, Microsoft, Dossia, Intel and Wal-Mart, in this evolving market space.

Vincent T. Kuraitis, JD, MBA, is the principal of Better Health Technologies LLC and author of e-CareManagement blog. He brings 24 years experience: president, vice president of corporate development, vice president of operations, regional director marketing and consultant. Kuraitis' experience spans more than 100 organizations.